Age-related Changes in the Diagnostic Assessment of Women with Severe Cervical Lesions
Overview
Affiliations
Objectives: To evaluate the effect of age on the diagnostic assessment of women with severe cervical intraepithelial neoplasia (CIN).
Methods: This retrospective observational study included 338 consecutive women with a diagnosis of CIN3 on cone specimen. Patients were divided into three groups according to age: < 35 years (Group A), 35-49 years (Group B), and ≥ 50 years (Group C). Clinical and colposcopic variables were compared, and human papillomavirus (HPV) genotype distribution was measured.
Results: The most common HPV genotype was HPV-16 (63.65%), followed by HPV-33 (7%), HPV-18 (6.2%), and HPV-31 (5.4%). The rate of the following high-grade lesion predictors was lower in Group C than in Groups A and B: HPV-16 infections (55.9% vs. 75% vs. 70.9%, respectively, p = 0.022); high-grade colposcopic impression (29.4% vs. 51.8% vs. 51.7%, respectively, p < 0.0001); and high-grade cytological changes (30.9% vs. 56.2% vs. 45.4%, respectively, p = 0.025). An endocervical lesion location was more frequent in Group C than in Groups A and B (55.6% vs. 6.8% vs. 11.8%, respectively, p < 0.0001).
Conclusion: Women aged 50 years and older with CIN3 showed a significant reduction of high-grade lesion predictors along with physiological confounding cervical changes (transformation zone type 3 and endocervical lesion location). The diagnostic work-up of cervical lesions in older women should provide their potential consideration as a special population.
Wang J, Wang C, Su T BMC Womens Health. 2024; 24(1):369.
PMID: 38915002 PMC: 11194937. DOI: 10.1186/s12905-024-03212-x.
Li Z, Zhou G, Jiang L, Wang M BMC Cancer. 2024; 24(1):401.
PMID: 38561685 PMC: 10985929. DOI: 10.1186/s12885-024-12186-w.
Xiang J, Han L, Fan Y, Feng B, Wu H, Hu C Int J Gen Med. 2021; 14:1983-1990.
PMID: 34045890 PMC: 8144902. DOI: 10.2147/IJGM.S308215.
Murakami I, Ohno A, Ikeda M, Yamashita H, Mikami M, Kobayashi Y Heliyon. 2020; 6(10):e05193.
PMID: 33088958 PMC: 7560578. DOI: 10.1016/j.heliyon.2020.e05193.
Giannella L, Delli Carpini G, Di Giuseppe J, Prandi S, Tsiroglou D, Ciavattini A J Oncol. 2019; 2019:7137891.
PMID: 31781217 PMC: 6875331. DOI: 10.1155/2019/7137891.